Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
This paper examines the evidence supporting treatments within the renin-angiotensin aldosterone system (RAS), the role cardioprotection plays within the management of hypertension, considerations around medication adherence, and the role of the nurse or nurse practitioner in guiding patients to achi...
Saved in:
| Main Author: | Nancy Houston Miller |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Nursing Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2010/101749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021-03-01) -
Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2015-01-01) -
THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01) -
Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
by: Audrey Koitka, et al.
Published: (2008-01-01) -
Renin‐Angiotensin‐Aldosterone System Profiling in Horses Before and After Exercise
by: Todd Holbrook, et al.
Published: (2025-03-01)